EAGLE PHARMACEUTICALS, INC. 8-K SEC Filings

Filed On	Filing
02 Dec 2024	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
27 Nov 2024	8-K: Changes in Registrant's Certifying Accountant
15 Nov 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
12 Nov 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more
31 Oct 2024	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more
02 Oct 2024	8-K: Results of Operations and Financial Condition; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
27 Aug 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
05 Aug 2024	8-K: Other Events
10 Jul 2024	8-K: Entry into a Material Definitive Agreement
29 May 2024	8-K: Other Events
22 May 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
15 May 2024	8-K: Entry into a Material Definitive Agreement
12 Apr 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
08 Mar 2024	8-K: Departure/Election of Directors or Officers; Compensation
01 Mar 2024	8-K: Entry into a Material Definitive Agreement
29 Feb 2024	8-K: Costs Associated with Exit or Disposal Activities
13 Feb 2024	8-K: Other Events
18 Jan 2024	8-K: Regulation FD Disclosure
16 Jan 2024	8-K: Entry into a Material Definitive Agreement
15 Dec 2023	8-K: Results of Operations and Financial Condition; Non-Reliance on Previously Issued Financial Statements

Comments